debt restructuring

Ardagh Group S.A. has announced a comprehensive recapitalization agreement with key financial players, including its controlling shareholder and a significant creditor coalition. The deal slashes $4.3 billion in debt via a debt-for-equity swap, extends bond maturities to 2030, and injects $1.5 billion in new capital. Ownership will transfer to noteholders, while Ardagh retains its Glass and Metal Packaging businesses. The transaction, expected to close by September 30, 2025, is subject to regulatory approvals.

NuRAN Wireless (NRRWF) achieved its first positive EBITDA in Q1 2025, as highlighted in a corporate update video featuring key executives. The company is currently negotiating potential debt restructuring to improve financial terms and seeking additional operating funds. While the positive EBITDA marks a significant milestone, the need for further funding and debt restructuring suggests ongoing financial considerations.

Organto Foods (OGOFF) completed the issuance of 4,380,000 shares to Jaluca Limited at $0.10 per share for advisory services related to debt restructuring. The company also announced its 2024 bonus program, totaling $822,000 for officers and key personnel, structured as 70% equity and 30% cash. The equity component has been earned but not yet disbursed, and will require TSXV approval upon issuance. This share issuance to Jaluca has negative implications by diluting the shares of stock holders.

New Zealand Energy Corp. is raising up to C$3 million through a private placement of common shares at C$0.18 each. The plan includes converting C$300,000 of debt from Charlestown Energy Partners and settling another loan with Vliet Financing B.V. by issuing shares. These transactions are classified as related-party dealings and require TSX Venture Exchange approval.

Elixxer Ltd. announces the upcoming resumption of trading following the revocation of a cease trade order. Key initiatives, including a new stock option plan, received shareholder approval at the AGM. The company has also strengthened its leadership with new CEO and CFO appointments and a refreshed Board of Directors. Strategic debt restructuring and bridge financing are in place. Elixxer is actively pursuing merger and acquisition opportunities and is involved in ongoing litigation regarding its investment in Freia Farmaceutici Srl.

Atico Mining secured a 30-year concession for Colombia’s El Roble copper-gold mine, stabilizing operations until 2055 and releasing $10M worth of pledged copper concentrate for immediate liquidity. The deal resolves a $12M arbitration liability, with $3M paid and $10.7M deferred to 2025–2026, aligned with projected cash flows. It transitions regulatory terms to modern mining codes but adds community development and state compensation costs. CEO Ganoza emphasized the concession’s role in shifting focus to growth and exploration. Risks include copper price volatility and inflation-adjusted settlement increases. The mine remains central to Atico’s revenue amid Colombia’s evolving mining policies.

Teva Pharmaceutical Industries has initiated a $2 billion refinancing through euro and dollar-denominated bonds via Dutch subsidiaries to restructure $2 billion in debt maturing between 2026-2031 (including high-coupon sustainability-linked notes). Leveraging current favorable market conditions, the move extends maturities, lowers interest costs, and maintains the parent company’s unconditional guarantees to ensure investor confidence. While introducing modest structural complexity, the strategy aligns with industry-wide debt optimization practices, mirroring recent Big Pharma restructurings.